Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Medtronic plc    MDT   IE00BTN1Y115

MEDTRONIC PLC

(MDT)
  Report
Delayed Quote. Delayed Nyse - 01/22 04:10:00 pm
116.58 USD   -1.13%
01/20Quarterly Report I 20/21
AQ
01/19Zimmer Biomet Appoints Chief Transformation Officer
MT
01/15MEDTRONIC : NANS 2021 Neuromodulation Investor Briefing
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: April 2018 2019 2020 2021 2022 2023
Capitalization1 107 576114 856133 078156 919--
Entreprise Value (EV)1 122 106130 332153 735177 787175 055171 910
P/E ratio 35,0x25,1x28,1x44,9x27,0x22,7x
Yield 2,32%2,34%2,34%1,94%2,05%2,16%
Capitalization / Revenue 3,59x3,76x4,60x5,24x4,82x4,56x
EV / Revenue 4,08x4,27x5,32x5,93x5,38x4,99x
EV / EBITDA 13,3x13,3x18,1x22,0x16,4x14,8x
Price to Book 2,12x2,30x2,62x3,12x3,00x2,85x
Nbr of stocks (in thousands) 1 355 3731 341 1511 340 1661 346 020--
Reference price (USD) 79,485,699,3117117117
Last update 05/24/201805/23/201905/21/202012/22/202012/22/202012/22/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: April 2018 2019 2020 2021 2022 2023
Net sales1 29 95330 55728 91329 96032 52634 433
EBITDA1 9 1739 7678 4728 06710 65611 650
Operating profit (EBIT)1 8 3528 8727 5656 9749 50610 340
Operating Margin 27,9%29,0%26,2%23,3%29,2%30,0%
Pre-Tax Profit (EBT)1 5 6755 1974 0554 3286 9188 042
Net income1 3 1044 6314 7893 4845 7826 845
Net margin 10,4%15,2%16,6%11,6%17,8%19,9%
EPS2 2,273,413,542,604,325,14
Dividend per Share2 1,842,002,322,262,392,52
Last update 05/24/201805/23/201905/21/202001/20/202101/20/202101/20/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: April 2018 2019 2020 2021 2022 2023
Net Debt1 14 53015 47620 65720 86818 13614 991
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,58x1,58x2,44x2,59x1,70x1,29x
Free Cash Flow1 4 7005 8736 0214 1396 6547 492
ROE (Net Profit / Equities) 12,9%14,1%12,3%11,3%15,9%16,8%
Shareholders' equity1 23 98832 92838 90330 87436 26940 783
ROA (Net Profit / Asset) 6,83%7,83%6,88%5,38%7,49%8,43%
Assets1 45 45559 14969 59864 74577 17781 196
Book Value Per Share2 37,437,237,837,438,940,9
Cash Flow per Share2 3,425,165,353,375,737,18
Capex1 1 0681 1341 2131 1951 3101 372
Capex / Sales 3,57%3,71%4,20%3,99%4,03%3,98%
Last update 05/24/201805/23/201905/21/202001/20/202101/20/202101/20/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (USD)
156 919 005 654
Net sales (USD)
28 913 000 000
Number of employees
90 000
Sales / Employee (USD)
321 256
Free-Float
99,9%
Free-Float capitalization (USD)
156 827 335 069
Avg. Exchange 20 sessions (USD)
403 747 375
Average Daily Capital Traded
0,26%
EPS & Dividend